C Li1, G Samsioe, C Iosif. 1. Department of Obstetrics and Gynecology, Lund University Hospital, Sweden.
Abstract
OBJECTIVE: The aim of this study was to evaluate the health-related quality of life in survivors of endometrial cancer (EC); and to identify common problems that they may encounter, in the hope of paving the way to improving their quality of life. STUDY DESIGN: We investigated and compared the health conditions and quality of life between EC survivors and the general population as a control group. There were 61 EC patients who were at clinical stage I-III and survived for 5-7 years after the primary treatments. The control group was composed of 527 healthy postmenopausal women. All of them completed a self-evaluated questionnaire pertaining to personal conditions, medical surveillance, individual well-being and quality of life. RESULTS: The EC survivors were divided into two groups: an older group (n = 34) and a younger group (n = 27). The latter was compared with the controls. In general, most of the EC survivors were old, low-educated women. The majority of them were in a poor condition. They were inactive, received medical surveillance and had regular medication. The distribution of various complications was higher in the older EC group while the climacteric symptoms were more common in the younger EC group. In both EC groups, the quality of life was lower than in the controls. The prevalence of somatic symptoms was higher in the older EC survivors and psychological problems were a common complaint of the younger EC survivors. CONCLUSION: The quality of life was poor in the EC survivors. To improve their life quality, earlier psychological counseling should be offered to EC survivors, in particular to younger and single women, and hormone replacement therapy (HRT) should be recommended, but on a selective basis, to those patients at low risk of cancer recurrence.
OBJECTIVE: The aim of this study was to evaluate the health-related quality of life in survivors of endometrial cancer (EC); and to identify common problems that they may encounter, in the hope of paving the way to improving their quality of life. STUDY DESIGN: We investigated and compared the health conditions and quality of life between EC survivors and the general population as a control group. There were 61 EC patients who were at clinical stage I-III and survived for 5-7 years after the primary treatments. The control group was composed of 527 healthy postmenopausal women. All of them completed a self-evaluated questionnaire pertaining to personal conditions, medical surveillance, individual well-being and quality of life. RESULTS: The EC survivors were divided into two groups: an older group (n = 34) and a younger group (n = 27). The latter was compared with the controls. In general, most of the EC survivors were old, low-educated women. The majority of them were in a poor condition. They were inactive, received medical surveillance and had regular medication. The distribution of various complications was higher in the older EC group while the climacteric symptoms were more common in the younger EC group. In both EC groups, the quality of life was lower than in the controls. The prevalence of somatic symptoms was higher in the older EC survivors and psychological problems were a common complaint of the younger EC survivors. CONCLUSION: The quality of life was poor in the EC survivors. To improve their life quality, earlier psychological counseling should be offered to EC survivors, in particular to younger and single women, and hormone replacement therapy (HRT) should be recommended, but on a selective basis, to those patients at low risk of cancer recurrence.
Authors: Allison M Quick; Leigh G Seamon; Mahmoud Abdel-Rasoul; Ritu Salani; Douglas Martin Journal: Int J Gynecol Cancer Date: 2012-05 Impact factor: 3.437
Authors: Sean M Hammer; Justin C Brown; Saya Segal; Christina S Chu; Kathryn H Schmitz Journal: Med Sci Sports Exerc Date: 2014-12 Impact factor: 5.411
Authors: Anna O Levin; Kristen M Carpenter; Jeffrey M Fowler; Brittany M Brothers; Barbara L Andersen; G Larry Maxwell Journal: Int J Gynecol Cancer Date: 2010-04 Impact factor: 3.437
Authors: Deborah Watkins Bruner; Andrea Barsevick; Chunqiao Tian; Marcus Randall; Robert Mannel; David E Cohn; Joel Sorosky; Nick M Spirtos Journal: Qual Life Res Date: 2006-10-11 Impact factor: 4.147
Authors: Karen Basen-Engquist; Cindy L Carmack; Heidi Perkins; Daniel Hughes; Susan Serice; Stacie Scruggs; Bernardine Pinto; Andrew Waters Journal: Psychol Sport Exerc Date: 2011-01-01
Authors: Xiaochen Zhang; Ashley F Haggerty; Justin C Brown; Robert Giuntoli; Lilie Lin; Fiona Simpkins; Lorraine T Dean; Emily Ko; Mark A Morgan; Kathryn H Schmitz Journal: Gynecol Oncol Date: 2015-08-22 Impact factor: 5.482
Authors: Kristina H Karvinen; Kerry S Courneya; Kristin L Campbell; Robert G Pearcey; George Dundas; Valerie Capstick; Katia S Tonkin Journal: Int J Behav Nutr Phys Act Date: 2007-05-30 Impact factor: 6.457